Trials / Completed
CompletedNCT03600831
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
A Randomized Phase Ⅱ/Ⅲ Trial of Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 434 (actual)
- Sponsor
- Huai'an First People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the effect of postoperative concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel plus cisplatin | cisplatin 25mg/m2 on day 1 and docetaxel 25mg/m2 on day 1 weekly for 5 weeks |
| RADIATION | radiotherapy | radiotherapy: 50Gy (2.0 Gy/fraction, 5 days a week) |
Timeline
- Start date
- 2018-08-20
- Primary completion
- 2022-05-30
- Completion
- 2023-12-31
- First posted
- 2018-07-26
- Last updated
- 2024-01-09
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03600831. Inclusion in this directory is not an endorsement.